Health Cluster Outlines Strategy at Medicen Day

Medicen Paris Region, one of Europe's leading health clusters, presented its new strategic priorities during the 3rd Medicen Day Meeting, (Feb 7) which gathered more than 200 stakeholders, including members, partners of the cluster, representatives from the Greater Paris region, the French investment bank bpifrance, the EIT Health European network and others. Medicen has just been selected by the French government to be part of the next phase of French competitiveness cluster development, from 2019 to 2022. The cluster will focus on two areas of expertise: support for member companies for growth in Europe and at an international level and the development of the precision medicine industry in France. Medicen will continue to provide high-end support to its member companies in Europe and internationally, in order to increase their funding and accelerate their development. The cluster will continue to be strongly involved in European projects, for which several members successfully applied. In 2018, Medicen was successful in supporting its members in the call for proposals for phase 2 of the SME Instrument programme, within which 2,500 companies have already been funded, out of 30,000 applicants. In France, out of more than 150 submitted projects, only eight were selected (four in healthcare), including three companies supported by Medicen. The winning companies will receive funding of between €1.5M and €2.5M ($1.7M – $2.8M).

Medicen will also strongly support its members in developing the field of precision medicine and its combined therapeutic solutions. "We are delighted to have been selected for the next phase of the clusters’ development. During our annual meeting we presented our ambitious strategy to our members and partners as well as to representatives of the Greater Paris Region. We strive to be a driving force for excellence in precision medicine and for the development of combined therapeutic solutions," said Stéphane Roques, general manager of the Medicen Paris Region cluster. "By 2022, we will strengthen our support to health entrepreneurs to enable the better and faster transformation of scientific and medical knowledge into economic value and jobs for the French sector.”